Advanced Diffuse Large B-Cell Lymphoma (DLBCL)
Also known as: Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Drug | Drug Name | Drug Description |
---|---|---|
DB00073 | Rituximab | A monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00073 | Rituximab | B-lymphocyte antigen CD20 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00316 | Acetaminophen | 2 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
DB09110 | Coenzyme M | 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 1 |
DB01234 | Dexamethasone | 2 | Active Not Recruiting | 1 |
DB01075 | Diphenhydramine | 2 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Active Not Recruiting | 1 |
DB00773 | Etoposide | 2 | Active Not Recruiting | 1 |
DB01181 | Ifosfamide | 2 | Active Not Recruiting | 1 |
DB00904 | Ondansetron | 2 | Active Not Recruiting | 1 |
DB00635 | Prednisone | 2 | Active Not Recruiting | 1 |
DB00073 | Rituximab | 2 | Active Not Recruiting | 1 |
DB00541 | Vincristine | 2 | Active Not Recruiting | 1 |